March 18, 2020
NIH: Availability of Administrative & Revision Supplements for COVID-19 Research
NIH Announces Availability of Supplements on COVID-19
The National Heart, Lung, and Blood Institute (NHLBI) issued a notice to highlight the urgent need for research on COVID-19 and on the biological effects of SARS-CoV-2.
Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.
Notice of Special Interest (NOSI) – Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)